Abbott Reports Third-Quarter 2025 Results and Reaffirms Full-Year Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Make sure you own this high-quality MedTech stock: RBC
October 17, 2025 4:00 PM EDTRBC Capital Markets reiterated its Outperform rating on one well-known MedTech stock in a note this week, calling it a high-quality company and saying it would be buyers following what it described as a quarter marked by transient headwinds.
The firm said Abbott's (NYSE: ABT) underlying business momentum is intact, even as the... More
Abbott (ABT) Reports In-Line Q3 EPS, Misses on Revenue; Offers FY25 EPS Guidance
October 15, 2025 7:32 AM EDTAbbott (NYSE: ABT) reported Q3 EPS of $1.30, in-line with the analyst estimate of $1.30. Revenue for the quarter came in at $11.37 billion versus the consensus estimate of $11.4 billion.
GUIDANCE:
Abbott sees FY2025 EPS of $5.12-$5.18, versus the consensus of $5.14.
For earnings history and earnings-related data on Abbott (ABT) click here.
... More